Critiquing the Stem Cell Board
By Editorial,
Los Angeles Times
| 02. 27. 2013
After years of resisting all criticisms of its operations, the California Institute for Regenerative Medicine is finally listening — a little. It spent $700,000 for an outside, high-level review that complimented the stem cell agency for funding an excellent portfolio of research projects, but also raised serious objections to the agency's structure, which the review said was likely to lead to financial conflicts of interest.
The criticisms were nothing new — many of the same points have been made since the agency was created by Proposition 71 in 2004 — but the positive response by the chairman of the agency's board was. The governing board is now making changes to address some of the long-standing issues.
Yet the agency isn't exactly embracing an ethical overhaul. It's doing just enough to address the criticisms without triggering any oversight from the Legislature. The modifications are more a bandage than a cure. Like a bandage, they will probably do, but only for a limited time.
The single biggest problem identified in the report by the Institute of Medicine, an arm of the National...
Related Articles
By Ron Leuty, San Francisco Business Times | 06.16.2025
23andMe's two-step sale to a nonprofit led by former CEO Anne Wojcicki is nothing more than a dance around California's genetic privacy law, state Attorney General Rob Bonta said in a filing late Monday, one day before a judge will...
By Staff, The Associated Press | 06.10.2025
PORTLAND, Ore. — Twenty-seven states and the District of Columbia on Monday filed a lawsuit in bankruptcy court seeking to block the sale of personal genetic data by 23andMe without customer consent. The lawsuit comes as a biotechnology company seeks...
By Donald Earl Collins, Al Jazeera | 05.23.2025
“The picture of the world’s richest man killing the world’s poorest children is not a pretty one,” Microsoft founder and billionaire philanthropist Bill Gates said of Elon Musk during an interview with The Financial Times earlier this month. Gates indirectly...
By Katie Sagaser, The DNA Exchange | 05.27.2025
Disclaimer: The views and opinions expressed in this piece are solely my own and do not represent those of my employer, past or present, or any affiliated institutions. This content is provided for general informational purposes only and does not...